New evidence shows second dengue infection can be more severe due to antibody levels

November 3, 2017 by Bob Yirka report
A TEM micrograph showing Dengue virus virions (the cluster of dark dots near the center). Image: CDC

(Medical Xpress)—A team of researchers from the U.S. and Nicaragua has found evidence that suggests people infected a second time by the dengue virus may experience a more severe form of dengue fever if their antibody levels are at a certain level. In their paper published in the journal Science, the team describes their study of the disease in children in Nicaragua over the course of 12 years and what they found.

Dengue fever is a malady caused by infection of the . On first infection, most people have relatively minor symptoms—fever and muscle and joint pain. For many people, a second infection is similar to the first, but for a third group, a second infection can cause what has come to be known as or (DHF/DSS). This form is much worse for the patient, as symptoms include loss of bodily fluid due to blood leaking from vessels, which in turn can lead to organ failure and possibly death. Health scientists have had difficulty agreeing on the cause of DHF/DSS, though some suggested it relates to the level of antibodies produced and maintained after the initial infection. In this new effort, the researchers have found evidence supporting this theory.

Antibodies are blood proteins that the body produces to battle specific antigens. To determine if, indeed, they play a role in dengue infections, the researchers took blood samples from 8,000 children ages two to 14 every year over the course of 12 years in Managua—each sample was tested for antibody levels. This allowed the researchers to monitor levels in children who were not infected, children who were, and children who were infected more than once. By comparing antibody levels in children that developed DHF/DSS to those who did not, the researchers were able to spot a trend—those children who had neither high nor low antibody levels did not develop the more severe reaction—it was those children who had medium levels. In fact, for this group, levels were approximately 7.64 times higher.

The researchers acknowledge that their results are just a first step in proving that are the true cause of more severe bouts of , but also suggest their findings my soon lead to requirements that new vaccines not be given to with medium levels of antibodies for fear that the shot might set off DHF/DSS.

Explore further: 8 in 10 Indonesian children has been infected with dengue

More information: Leah C. Katzelnick et al. Antibody-dependent enhancement of severe dengue disease in humans, Science (2017). DOI: 10.1126/science.aan6836

Abstract
For dengue viruses (DENV1-4), a specific range of antibody titer has been shown to enhance viral replication in vitro and severe disease in animal models. Although suspected, such antibody-dependent enhancement (ADE) of severe disease has not been shown to occur in humans. Using multiple statistical approaches to study a long-term pediatric cohort in Nicaragua, we show that risk of severe dengue disease is highest within a narrow range of pre-existing anti-DENV antibody titers. By contrast, we observe protection from all symptomatic dengue disease at high antibody titers. Thus, immune correlates of severe dengue must be evaluated separately from correlates of protection against symptomatic disease. These results have implications for studies of dengue pathogenesis and for vaccine development, because enhancement, not just lack of protection, is of concern.

Related Stories

8 in 10 Indonesian children has been infected with dengue

June 16, 2017
Indonesia has one of the highest burdens of dengue fever, a mosquito-borne virus, in the world, and children account for many cases. Well over half of all children in urban areas are infected with dengue by the age of 5, ...

Gene expression patterns and immune signatures associated with dengue fever immune response identified

August 31, 2017
(Phys.org)—A large team of researchers from France and Cambodia has identified gene expression patterns and immune signatures associated with dengue fever symptoms in people who demonstrate an immune response. In their ...

Antibody protects against Zika and dengue, mouse study shows

September 25, 2017
Brazil and other areas hardest hit by the Zika virus - which can cause babies to be born with abnormally small heads - are also home to dengue virus, which is spread by the same mosquito species.

Prior dengue or yellow fever exposure does not worsen Zika infection in monkeys

August 4, 2017
Rhesus macaques previously infected with dengue or yellow fever viruses appear to be neither more nor less susceptible to severe infection with Zika virus, according to new research published in PLOS Pathogens.

Pregnancy problems not necessarily tied to Zika viral load or Dengue fever

June 13, 2017
UCLA-led researchers have found that Zika viral load and the degree of Zika symptoms during pregnancy were not necessarily associated with problems during pregnancy or fetal abnormalities at birth. They also found that the ...

Study maps potential route to effective dengue vaccines

January 18, 2016
(Medical Xpress)—The mosquito-borne dengue virus infects up to 390 million people a year. Symptoms of dengue fever include a measles-like rash, fever, body aches and joint pain. In a small subset of cases, the disease develops ...

Recommended for you

Gastric acid suppressant lansoprazole may target tuberculosis

November 21, 2017
A cheap and widely used drug, used to treat conditions such as heartburn, gastritis and ulcers, could work against the bacteria that cause tuberculosis (TB), according to new research from UCL and the London School of Hygiene ...

Improving prediction accuracy of Crohn's disease based on repeated fecal sampling

November 21, 2017
Researchers at the University of California San Diego Center for Microbiome Innovation (CMI) have found that sampling the gut microbiome over time can provide insights that are not available with a single time point. The ...

Anti-malaria drug shows promise as Zika virus treatment

November 17, 2017
A new collaborative study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) and UC San Diego School of Medicine has found that a medication used to prevent and treat malaria may also be effective ...

Decrease in sunshine, increase in Rickets

November 17, 2017
A University of Toronto student and professor have teamed up to discover that Britain's increasing cloudiness during the summer could be an important reason for the mysterious increase in Rickets among British children over ...

Scientists identify biomarkers that indicate likelihood of survival in infected patients

November 17, 2017
Scientists have identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.

Research team unlocks secrets of Ebola

November 16, 2017
In a comprehensive and complex molecular study of blood samples from Ebola patients in Sierra Leone, published today (Nov. 16, 2017) in Cell Host and Microbe, a scientific team led by the University of Wisconsin-Madison has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.